Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-07-11 | New | $6,356,956 | $6,356,956 | Equity Only | 06b | SEC link |
2023-12-13 | Amended | $7,982,500 | $3,432,500 | Equity Only | 06b | SEC link |
2023-11-02 | New | $4,550,000 | $4,550,000 | Equity Only | 06b | SEC link |
2023-01-25 | Amended | $15,297,306 | $2,255,000 | Equity Only | 06b | SEC link |
2023-01-03 | New | $13,042,306 | $13,042,306 | Equity Only | 06b | SEC link |
2021-03-31 | Amended | $4,995,000 | $2,220,000 | Equity Only | 06b | SEC link |
2020-11-25 | New | $2,775,000 | $2,775,000 | Equity Only | 06b | SEC link |
2019-07-12 | New | $12,500,000 | $12,500,000 | Equity Only | 06b | SEC link |
Name | Role |
---|---|
Jeff Duncan | Executive |
Ronald Eibensteiner | Director |
Jake Isenburg | Executive |
Steve Jagodzinski | Executive |
Erwin Kelen | Director |
Heather Kotila | Executive |
Tom Kouchoukos | Executive |
Jerrod Krueger | Executive |
Phillip Nalbone | Director |
Phil Nalbone | Director |
Carrie Powers | Director, Executive |
Howard Root | Director |
Jeff Ross | Director |
Greg Smock | Executive |
Tina Walters | Executive |
Alan Woldt | Director |